TRCT
OSIR

Tower Research Capital (TRC)’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Tower Research Capital (TRC)’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,011
Closed -$5K – 4639
2016
Q4 		$5K Buy
+1,011
New +$5.18K ﹤0.01% 3117
2016
Q3 		– Sell
-1,213
Closed -$6.21K – 5282
2016
Q2 		$6K Buy
1,213
+937
+339% +$5.04K ﹤0.01% 3329
2016
Q1 		$2K Sell
276
-695
-72% -$4.85K ﹤0.01% 3595
2015
Q4 		$10K Sell
971
-2,473
-72% -$33.6K ﹤0.01% 2221
2015
Q3 		$64K Buy
3,444
+2,918
+555% +$56.3K 0.01% 854
2015
Q2 		$10K Sell
526
-463
-47% -$8.19K ﹤0.01% 2764
2015
Q1 		$17K Buy
989
+258
+35% +$4.33K ﹤0.01% 2409
2014
Q4 		$12K Buy
731
+730
+73,000% +$9.77K ﹤0.01% 2041
2014
Q3 		$0 Buy
+1
New +$14 ﹤0.01% 5469
2014
Q2 		– Sell
-782
Closed -$10K – 5417
2014
Q1 		$10K Sell
782
-56
-7% -$876 ﹤0.01% 2672
2013
Q4 		$13K Sell
838
-7,002
-89% -$112K ﹤0.01% 2797
2013
Q3 		$130K Buy
+7,840
New +$116K 0.01% 1076

Other funds holding OSIR

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Tower Research Capital (TRC)'s OSIR Position: Q1 2017 in Review

Tower Research Capital (TRC) sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 1,011 shares — an estimated $5K sold.

Tower Research Capital (TRC) first reported a position in OSIR in Q3 2013 and held it in 12 quarters. The position peaked at $130K in Q3 2013. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

  • Tower Research Capital (TRC) reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,011 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $5K.
  • Tower Research Capital (TRC) first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2013 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s Osiris Therapeutics, Inc. Common Stock position peaked at $130K in Q3 2013.
  • 11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.